SuperMush raises $3M Series A for functional mushroom wellness products

Wellness brand SuperMush has raised $3 million in a Series A funding round led by NDude, a healthcare and wellness-focused investment firm.

SuperMush makes functional products built on research-backed ingredients, including nootropics, adaptogens and functional mushrooms. Its product range expanded with the launch of Shilajit, Creatine and Lion’s Mane gummies.

Founded in 2022 by Alli Schaper and Brian Friedman, the startup sells through retail and direct-to-consumer channels. Its products are available in more than 2,000 stores across the US, including over 1,000 Target locations and Sprouts stores, alongside its website and Amazon.

The capital will fund product expansion, deeper investment in high-efficacy formulations, and the team and infrastructure needed to reach more customers.

“NDude Labs invests in differentiated, science-backed products and founders with the vision and grit to build enduring brands,” said Vikram Sehgal, COO at NDude Labs.

“We are so excited to be partnering with NDude Labs for this next phase of our evolution,” said Alli Schaper, co-founder and CEO of SuperMush.

Brian Friedman, co-founder of SuperMush, added, “We’re extremely excited to partner with NDude Labs on this next chapter as we evolve SuperMush into the #1 premium functional supplement brand for active lifestyles.

With their support, we’re going to create the most effective, science-backed supplements using clinically studied ingredients at meaningful doses to help people think better, move better and feel their best.”